338 related articles for article (PubMed ID: 27224058)
1. Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges.
Ceresoli GL; Bonomi M; Sauta MG
Expert Rev Anticancer Ther; 2016 Jul; 16(7):673-5. PubMed ID: 27224058
[No Abstract] [Full Text] [Related]
2. Is the patient with mesothelioma without hope?
Maat AP; Cornelissen R; Bogers AJ; Takkenberg JJ
Future Oncol; 2015; 11(24 Suppl):11-4. PubMed ID: 26638916
[TBL] [Abstract][Full Text] [Related]
3. A catalogue of treatment and technologies for malignant pleural mesothelioma.
Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for immunotherapy in malignant pleural mesothelioma?
Tartarone A; Lerose R; Aieta M
Med Oncol; 2018 May; 35(7):98. PubMed ID: 29845408
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.
Wong RM; Ianculescu I; Sharma S; Gage DL; Olevsky OM; Kotova S; Kostic MN; Grundfest WS; Hou D; Cameron RB
Am J Respir Cell Mol Biol; 2014 May; 50(5):870-5. PubMed ID: 24450537
[TBL] [Abstract][Full Text] [Related]
6. Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.
Bograd AJ; Suzuki K; Vertes E; Colovos C; Morales EA; Sadelain M; Adusumilli PS
Cancer Immunol Immunother; 2011 Nov; 60(11):1509-27. PubMed ID: 21913025
[TBL] [Abstract][Full Text] [Related]
7. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic strategies for malignant pleural mesothelioma.
Bonelli MA; Fumarola C; La Monica S; Alfieri R
Biochem Pharmacol; 2017 Jan; 123():8-18. PubMed ID: 27431778
[TBL] [Abstract][Full Text] [Related]
9. An unusual presentation of malignant pleural mesothelioma.
Lacle MM; van Oosterhout MF
J Thorac Oncol; 2013 Jul; 8(7):e63-4. PubMed ID: 23774388
[No Abstract] [Full Text] [Related]
10. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
[TBL] [Abstract][Full Text] [Related]
11. Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?
Treasure T
Future Oncol; 2015; 11(24 Suppl):7-10. PubMed ID: 26638915
[TBL] [Abstract][Full Text] [Related]
12. Pathologic complete remission of malignant pleural mesothelioma after combined modality treatment: a case report.
Moubax K; Van Damme V; Nafteux P; Van den Heuvel M; Verbeken E; Lievens Y; Nackaerts K
Acta Clin Belg; 2013; 68(5):386-8. PubMed ID: 24579249
[TBL] [Abstract][Full Text] [Related]
13. 3-Year CheckMate743 outcomes: ringing in immunotherapy for the treatment of malignant pleural mesothelioma.
Cedres S; Felip E
Ann Oncol; 2022 May; 33(5):457-459. PubMed ID: 35306158
[No Abstract] [Full Text] [Related]
14. Pleural mesothelioma: tackling a deadly cancer.
The Lancet Respiratory Medicine
Lancet Respir Med; 2019 Feb; 7(2):99. PubMed ID: 30660508
[No Abstract] [Full Text] [Related]
15. Follow the Leader? Can Malignant Pleural Mesothelioma Follow Non-small Cell Lung Cancer's Lead With Immunotherapy?
Contreras N; Litle VR
Ann Thorac Surg; 2022 Nov; 114(5):e361. PubMed ID: 35192794
[No Abstract] [Full Text] [Related]
16. Immunotherapy in relapsed mesothelioma.
Brosseau S; Dhalluin X; Zalcman G; Scherpereel A
Immunotherapy; 2018 Feb; 10(2):77-80. PubMed ID: 29260624
[No Abstract] [Full Text] [Related]
17. Clinical Response of Live-Attenuated,
Hassan R; Alley E; Kindler H; Antonia S; Jahan T; Honarmand S; Nair N; Whiting CC; Enstrom A; Lemmens E; Tsujikawa T; Kumar S; Choe G; Thomas A; McDougall K; Murphy AL; Jaffee E; Coussens LM; Brockstedt DG
Clin Cancer Res; 2019 Oct; 25(19):5787-5798. PubMed ID: 31263030
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
19. Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Signorelli D; Macerelli M; Proto C; Vitali M; Cona MS; Agustoni F; Zilembo N; Platania M; Trama A; Gallucci R; Ganzinelli M; Pelosi G; Pastorino U; de Braud F; Garassino MC; Lo Russo G
Tumori; 2016; 102(1):18-30. PubMed ID: 26481865
[TBL] [Abstract][Full Text] [Related]
20. Optimal Therapy of Advanced Stage Mesothelioma.
Disselhorst MMJ; Burgers SJA; Baas P
Curr Treat Options Oncol; 2017 Aug; 18(8):48. PubMed ID: 28681207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
